Articles By Rob Wright, Chief Editor

The Essentials Of Your BIO 2018 Educational Session Proposal
The Essentials Of Your BIO 2018 Educational Session Proposal Next week, BIO will invite biopharmaceutical industry experts to submit educational topic session proposals for the 2018 BIO International Convention in Boston, June 4 - 7. The 2018 call for sessions and speakers opens on Thursday, September 14, and closes on Thursday, October 12, 2017. As I have (once again) agreed to serve as a BIO educational program planning committee co-chair, I have a vested interest in its success. My goal in helping...  Continue Reading...
  • Life, Liberty, And The Pursuit Of Healthiness
    Life, Liberty, And The Pursuit Of Healthiness

    A little over two years ago, my wife’s employer informed her that, if I was able to get health insurance through my employer, I would have to do so. We didn’t think much about the change until my wife went to pick up a prescription for me in January 2016.

  • Behind The Scenes Of Allergan’s Social Contract
    Behind The Scenes Of Allergan’s Social Contract

    The story behind Allergan’s bold decision to formalize its social contract with patients told to our Chief Editor by Brent Saunders, Allergan’s chairman, president, and CEO.

  • P3s: How To Get The Good …Without The Bad
    P3s: How To Get The Good …Without The Bad

    At this year’s BIO International Convention in San Diego (June 19 – 22), I moderated a session, Navigating A Clear Path To Public-Private Partnerships, and we talked about the good, the bad, and the ugly of P3s. After a brief introduction, the first question was posed, resulting in the following edited dialogue.

  • My Top 10 Quotes From David Hung, Axovant Sciences CEO
    My Top 10 Quotes From David Hung, Axovant Sciences CEO

    Forbes once called Merck’s Ken Frazier a “quote machine,” but I’d say David Hung is just as deserving of that moniker. I interviewed Hung, the new CEO of Axovant Sciences, at the BIO conference in June, and throughout our discussion I found myself smiling. Hung, who saw the company he founded, Medivation, be acquired by Pfizer for $14.3 billion, will be the subject of a Life Science Leader magazine exclusive feature in our October 2017 issue. During our conversation he provided a plethora of statements I found so memorable that I decided to put together a list of my top 10 favorites — listed in the order they occurred during conversation.

  • Sanat Chattopadhyay — Shaping Merck’s Manufacturing Future
    Sanat Chattopadhyay — Shaping Merck’s Manufacturing Future

    It’s been a little over a year since Sanat Chattopadhyay was named president of Merck Manufacturing Division (MMD), and this month he gives an exclusive interview on the status of the division’s transformational turnaround.

  • Has Your Company Ever Been Held For Ransom?
    Has Your Company Ever Been Held For Ransom?

    Have you ever experienced a ransomware nightmare? Merck did recently, and chief editor Rob Wright talks about that incident and the questions raised from such an attack.

  • What Do Partnering For Cures And A GSK Plant Tour Have In Common?
    What Do Partnering For Cures And A GSK Plant Tour Have In Common?

    In July I had two interesting opportunities. The first was on July 12, 2017 when I attended the Partnering For Cures (Twitter hashtag #FCP4C) conference in Boston. The second took place on July 19, when I got to tour GSK’s vaccine manufacturing facility in Marietta, PA. And while you might not think that a biopharmaceutical conference and a manufacturing facility would have much in common, in actuality they do, as both are focused on delivering safe and effective, high-quality medicines to patients as quickly and efficient as possible. Here are some highlights from my recent experiences.

  • In Memoriam Of One Of Biopharma’s Great Mentors
    In Memoriam Of One Of Biopharma’s Great Mentors

    It was the fall of 2016 when I began pursuing the idea for this month’s cover feature: Interview a group of former CEOs to gain their perspectives on our industry’s extremely bright future balanced with its currently tarnished image. What advice might these mentors have for today’s current industry executives on drug pricing, corporate culture creation, and so much more? But on Friday, May 12, 2017, the project turned bittersweet as one of the participants, Henri Termeer (71), died after collapsing in his home in Marblehead, MA.

  • Balancing Biopharma’s Bright Future Against Its Tarnished Image —  Insights From 6 Retired CEOs
    Balancing Biopharma’s Bright Future Against Its Tarnished Image — Insights From 6 Retired CEOs

    Find out what life is like after retiring from a pharma CEO role. These 6 leaders  speak — unrestrained by corporate lawyers and PR teams — about the current state of the industry.

Rob Wright

Rob Wright



Rob Wright is the chief editor of Life Science Leader magazine. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, co-chaired, moderated, and served as a speaker at industry and academic conferences and is the past co-chair for the 2015 BIO International conference educational planning committee. Wright’s 100+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma.